Bill Text: MO HB1523 | 2010 | Regular Session | Introduced

---

Bill Title: Requires the Department of Health and Senior Services to develop and disseminate information regarding uterine fibroids to health care providers and the public

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Introduced - Dead) 2010-02-23 - Voted Do Pass (H) [HB1523 Detail]

Download: Missouri-2010-HB1523-Introduced.html

---

SECOND REGULAR SESSION

HOUSE BILL NO. 1523

95TH GENERAL ASSEMBLY

---

 

 

INTRODUCED BY REPRESENTATIVE HOSKINS (80).

4269L.01I                                                                                                                                                  D. ADAM CRUMBLISS, Chief Clerk

---

 

AN ACT

To amend chapter 191, RSMo, by adding thereto one new section relating to uterine fibroids.

---

Be it enacted by the General Assembly of the state of Missouri, as follows:

            Section A. Chapter 191, RSMo, is amended by adding thereto one new section, to be known as section 191.945, to read as follows:

            191.945. 1. The department of health and senior services shall, subject to appropriations, develop and disseminate to the public information regarding uterine fibroids, including information on:

            (1) The incidence and prevalence of uterine fibroids among women;

            (2) The elevated risk for minority women to develop uterine fibroids; and

            (3) The availability, as medically appropriate, of a range of treatment options for symptomatic uterine fibroids.

 

The department may disseminate information under this subsection directly or through arrangements with nonprofit organizations, consumer groups, institutions of higher education, the media, or federal, state, or local agencies.

            2. The department of health and senior services shall, subject to appropriations, develop and disseminate to health care providers information on uterine fibroids for the purpose of ensuring that health care providers remain informed about current information on uterine fibroids. Such information shall include, but not be limited to, the elevated risk for minority women to develop uterine fibroids and the range of available options for the treatment of symptomatic uterine fibroids.

            3. As used in this section, "minority women" means women who are members of a racial and ethnic minority group, as defined in 42 U.S.C. Section 300u-6(g).

•